HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Krzysztof W Nowak Selected Research

Obesity

10/202130-Day spexin treatment of mice with diet-induced obesity (DIO) and type 2 diabetes (T2DM) increases insulin sensitivity, improves liver functions and metabolic status.
1/2021Adropin Slightly Modulates Lipolysis, Lipogenesis and Expression of Adipokines but Not Glucose Uptake in Rodent Adipocytes.
12/2020Short-term administration of spexin in rats reduces obesity by affecting lipolysis and lipogenesis: An in vivo and in vitro study.
10/2019Effects of adropin on proliferation and differentiation of 3T3-L1 cells and rat primary preadipocytes.
11/2018Interleukin 4 affects lipid metabolism and the expression of pro-inflammatory factors in mature rat adipocytes.
4/2017Changes in obestatin gene and GPR39 receptor expression in peripheral tissues of rat models of obesity, type 1 and type 2 diabetes.
6/2012Neuropeptide B and W regulate leptin and resistin secretion, and stimulate lipolysis in isolated rat adipocytes.
8/2007Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition.
3/2007Neuropeptide W exerts a potent suppressive effect on blood leptin and insulin concentrations in the rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Krzysztof W Nowak Research Topics

Disease

14Body Weight (Weight, Body)
08/2022 - 01/2002
9Type 2 Diabetes Mellitus (MODY)
08/2022 - 10/2006
9Obesity
10/2021 - 03/2007
5Insulin Resistance
08/2022 - 12/2015
4Hyperglycemia
07/2013 - 06/2003
3Inflammation (Inflammations)
01/2020 - 11/2016
2Pain (Aches)
06/2021 - 12/2019
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2014 - 07/2013
2Iron Deficiencies
06/2014 - 12/2012
1Dyslipidemias (Dyslipidemia)
10/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2019
1Asthma (Bronchial Asthma)
11/2018
1Hyperphagia (Overeating)
06/2012
1Insulinoma
10/2009
1AIDS-Related Complex (ARC)
01/2006

Drug/Important Bio-Agent (IBA)

13Glucose (Dextrose)FDA LinkGeneric
08/2022 - 10/2006
8LeptinIBA
10/2021 - 01/2002
7LipidsIBA
08/2022 - 04/2017
7Insulin (Novolin)FDA Link
10/2021 - 03/2002
7Glucagon (Glukagon)FDA Link
10/2021 - 06/2003
44-nitrophenethyl bromide (NPB)IBA
06/2021 - 03/2007
3Peptides (Polypeptides)IBA
01/2020 - 12/2015
3Proteins (Proteins, Gene)FDA Link
10/2019 - 04/2017
3GhrelinIBA
06/2017 - 12/2015
2Triglycerides (Triacylglycerol)IBA
08/2022 - 06/2017
2EnzymesIBA
08/2022 - 06/2017
2CholesterolIBA
08/2022 - 06/2017
2Streptozocin (Streptozotocin)FDA Link
10/2014 - 07/2013
2Ferritins (Ferritin)IBA
06/2014 - 12/2012
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2021
1AdiponectinIBA
10/2021
1Peptide Hormones (Polypeptide Hormones)IBA
01/2021
1MicroRNAs (MicroRNA)IBA
01/2020
1Immunoglobulin E (IgE)IBA
01/2020
1NeuropeptidesIBA
12/2019
1Interleukin-4 (Interleukin 4)IBA
11/2018
1CytokinesIBA
11/2018
1Alanine Transaminase (SGPT)IBA
06/2017
1GlycogenIBA
06/2017
1gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
06/2017
1HDL LipoproteinsIBA
06/2017
1LDL Lipoproteins (beta Lipoproteins)IBA
06/2017
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
06/2017
1FructosamineIBA
06/2017
1ResistinIBA
11/2016
1AcidsIBA
12/2015
1IronIBA
06/2014
1DNA (Deoxyribonucleic Acid)IBA
07/2013
1Nucleotide AptamersIBA
07/2013
1Glucagon Receptors (Glucagon Receptor)IBA
07/2013
1CalciumIBA
10/2009
1ColforsinIBA
10/2009
1Somatostatin Receptors (Somatostatin Receptor)IBA
08/2007
1Liver GlycogenIBA
08/2007
1Hormones (Hormone)IBA
03/2007
1Blood Glucose (Blood Sugar)IBA
10/2006
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
10/2006
1OrexinsIBA
03/2002

Therapy/Procedure

1Therapeutics
10/2021
1Aftercare (After-Treatment)
10/2006
1Injections
03/2002